FDAFDA · Food and drugs·Recall number D-128-2013
CABERGOLINE Tablets, 0.5 mg, RX only, 8 count bottles, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960 NDC 0093-5420-88
Published January 23, 2013 · Recall initiated: April 24, 2012
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Impurities/Degradation Products: This lot of product will not meet the impurity specification over shelf life
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- CABERGOLINE
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- Distributor
- Nationwide
- Lot
- Lot number 6A007046V, exp 07/12
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.